IL-33/ST2轴在CpG诱导的巨细胞激活综合征中的作用
Yuanji Dong1,2, Rongfen Gao1, Kailin He1
1Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Journal of immunology research
|October 16, 2023
概括
IL-33/ST2轴对小鼠的巨细胞激活综合征 (MAS) 没有显著影响. 淘汰IL-33或ST2并没有改变疾病严重程度,这表明这种途径不是MAS的可行的治疗标.
科学领域:
- 免疫学 免疫学 免疫学
- 炎症生物学 炎症生物学
背景情况:
- 巨细胞激活综合征 (MAS) 是一种严重的,致命的炎症状况,其特征是高水平的细胞因子和器官功能障碍.
- 之前的研究表明,ST2在T细胞过度活化中的有害作用在血细胞淋巴细胞细胞瘤模型中.
- IL-33/ST2轴在MAS病原体中的参与在很大程度上仍未被探索.
研究的目的:
- 研究IL-33/ST2信号通路在MAS小鼠模型中的作用.
- 确定IL-33/ST2轴是否影响CpG诱导的MAS的发展和严重程度.
主要方法:
- 在一只小鼠模型中,使用反复注射细胞氨酸酸氨酸 (CpG) 来诱导MAS.
- 通过免疫组织化学和qPCR在肝脏和脏组织中评估IL-33和ST2表达水平.
- 在野生型和IL-33/ST2淘汰赛小鼠中量化了细胞因子水平,有机巨变和免疫细胞群 (巨细胞,T淋巴细胞).
主要成果:
- CpG注射成功诱导了MAS,其特征是高细胞动血和肝大.
- 在MAS小鼠组织中观察到IL-33阳性细胞的显著减少,而ST2表达显示出增加的趋势.
- IL-33和ST2淘汰的小鼠表现出与野生类型对照相比较的MAS严重程度,包括细胞因子风暴,有机巨变和免疫细胞概况.
结论:
- IL-33/ST2轴似乎在CpG诱导的MAS的发病过程中发挥的作用很小.
- 针对IL-33/ST2通路并不能为MAS提供治疗潜力.
- 可能需要进一步的研究来确定其他关键途径参与MAS进展.
相关概念视频
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K


